Onward Therapeutics (Onward) and Institut du Cancer de Montpellier (ICM) announced today the execution of an exclusive collaboration and worldwide option and license agreement based on a research program in onco-metabolism being conducted by ICM ...
CONTINUUS Pharmaceuticals Inc. received a $69.3 million U.S. government contract to facilitate domestic production of three vital medicines used to treat critically ill patients, including COVID-19.